Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novavax, Inc. - Common Stock
(NQ:
NVAX
)
9.200
-0.030 (-0.33%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Novavax, Inc. - Common Stock
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
61
62
Next >
Novavax Has Limited Pipeline Upside, Says BofA Analyst: What's Next?
↗
May 20, 2022
Although Novavax, Inc’s (NASDAQ: NVAX) shares have tanked 59% year to date, there is still room for a further decline, according to BofA Securities. The Novavax Analyst: Alec Stranahan initiated...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 20, 2022
↗
May 20, 2022
Upgrades
Via
Benzinga
7 Growth Stocks to Avoid Until the Market Crashes Again
↗
May 20, 2022
Not every investment idea offers a compelling discount. These growth stocks aren't what they once were.
Via
InvestorPlace
3 Oversold Biotech Stocks to Buy Now
↗
May 19, 2022
Looking for oversold biotech stocks? These three have all seen significant drops this year despite promising catalysts for the future.
Via
InvestorPlace
Avoid Novavax Stock as Its Hopes Dwindle
↗
May 13, 2022
The FDA approval is the only hope for Novavax. If you own it, hold NVAX stock until the approval but do not take a new position right now.
Via
InvestorPlace
Why Novavax Stock Is Plunging Today
↗
May 10, 2022
Novavax Inc (NASDAQ: NVAX) shares are trading lower Tuesday after the company reported worse-than-expected financial results.
Via
Benzinga
Novavax Crashes As Alternative To Pfizer, Moderna Covid Shots Lags Estimates
↗
May 09, 2022
Novavax posted lighter-than-expected sales of its Covid shot, which doesn't use mRNA.
Via
Investor's Business Daily
Biden Says US Ready To Share COVID-19 Vaccine Related Technology
↗
May 13, 2022
Via
Benzinga
White House Says Currently No Plans To Share COVID-19 Shots With North Korea Battling Outbreak
↗
May 13, 2022
The Biden administration says it currently has no plans to share COVID-19 vaccines with North Korea, Reuters reported citing White House press secretary Jen Psaki. However, it supported providing aid...
Via
Benzinga
Cboe's Weekly Market Recap: May 2nd To May 6th
↗
May 11, 2022
Photo by m. on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Via
Benzinga
99 Biggest Movers From Yesterday
↗
May 12, 2022
Gainers Armstrong Flooring, Inc. (NYSE: AFI) shares jumped 237% to settle at $0.49 on Wednesday after a 13D filing showed Esopus Creek Advisors LLC disclosed a 5.1% active stake in the company.
Via
Benzinga
52 Stocks Moving In Wednesday's Mid-Day Session
↗
May 11, 2022
Gainers Trecora Resources (NYSE: TREC) shares jumped 26.6% to $9.56 as the company agreed to be acquired by an affiliate of Balmoral Funds at $9.81 per share in cash or an enterprise value of $247...
Via
Benzinga
Bausch Health (BHC) Stock Plunges 25% After Bausch + Lomb IPO
↗
May 10, 2022
Bausch Health (BHC) stock is falling on Tuesday following the release of its earnings report for the first quarter of 2022.
Via
InvestorPlace
Why Moderna Shares Are Trading Lower Following Novavax's Earnings Report
↗
May 10, 2022
Moderna Inc (NASDAQ: MRNA) shares are trading lower by 3.15% at $131.52.
Via
Benzinga
77 Stocks Moving In Tuesday's Mid-Day Session
↗
May 10, 2022
Gainers
Via
Benzinga
PTON Stock Alert: 9 Things to Know as Peloton Plummets 15% After Reporting Earnings
↗
May 10, 2022
Peloton (PTON) is the top trending stock on Yahoo today as the company's shares fall after releasing its fiscal Q3 2022 earnings report.
Via
InvestorPlace
NVAX Stock Falls 20% as Novavax Misses Q1 Estimates
↗
May 10, 2022
The drug maker's stock is falling sharply on news that the company missed the profit and revenue expectations of analysts.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
May 10, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
↗
May 10, 2022
Good morning! We're starting off another busy day of trading with a breakdown of the biggest pre-market stock movers for Tuesday!
Via
InvestorPlace
Novavax's 22% Post-Earnings Plunge: 5 Factors That Took Toll
↗
May 10, 2022
Novavax, Inc. (NASDAQ: NVAX) shares slumped 22.27% after-hours on Monday, reacting to its quarterly financial report.
Via
Benzinga
30 Stocks Moving in Tuesday's Pre-Market Session
↗
May 10, 2022
Gainers Vroom, Inc. (NASDAQ: VRM) shares rose 38% to $1.49 in pre-market trading after the company reported better-than-expected Q1 results.
Via
Benzinga
A Peek Into The Markets: US Stock Futures Higher Ahead Of Fed Speakers
↗
May 10, 2022
Pre-open movers
Via
Benzinga
5 Stocks To Watch For May 10, 2022
↗
May 10, 2022
Some of the stocks that may grab investor focus today are:
Via
Benzinga
Novavax Stock Is Too Sickly To Buy
↗
May 09, 2022
Rivals pharmaceutical companies have beaten Novavax to market with a range of Covid-19 treatments, leaving NVAX stock in the dust.
Via
InvestorPlace
Check Out What Whales Are Doing With NVAX
↗
May 09, 2022
Someone with a lot of money to spend has taken a bullish stance on Novavax (NASDAQ:NVAX). And retail traders should know. We noticed this today when the big position showed up on publicly available...
Via
Benzinga
Why Novavax Shares Are Falling After Hours
↗
May 09, 2022
Novavax Inc (NASDAQ: NVAX) shares are trading lower in Monday's after-hours session after the company reported worse-than-expected financial results.
Via
Benzinga
How Novavax Stock Looks Headed Into Q1 Earnings
↗
May 09, 2022
Novavax, Inc. (NASDAQ: NVAX) is set to print its first-quarter financial results after the market close on Thursday. The stock was trading more than 6% lower, at one point, heading into the event.
Via
Benzinga
The Week Ahead In Biotech (May 8-14): Bausch Health Headlines Smid-Cap Earnings, Veru's Pre-EUA Meeting, Conference Presentations And More
↗
May 09, 2022
Biotech stocks declined yet again in the week ending May 6, dragged lower by macroeconomic concerns following the Federal Reserve's 50-basis-point rate hike. The iShares Biotechnology ETF (NASDAQ:...
Via
Benzinga
Jim Cramer Shares His Thoughts On Chubb, Novavax And More
↗
May 09, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes the long-term prospects of Plug Power Inc (NASDAQ: PLUG). "Right now, this is a very tough day for a stock like Plug Power," he added.
Via
Benzinga
A Peek Into The Markets: US Stock Futures Signal Lower Start On Wall Street
↗
May 09, 2022
Pre-open movers
Via
Benzinga
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
61
62
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today